Testing for Neuromyelitis Optica
Dr. Pittock reviews neuromyelitis optica (NMO), a severe, inflammatory demyelinating disease of the central nervous system that predominantly affects women and disproportionately affects African-Americans and Asians. He discusses how an NMO-specific biomarker can be used to differentiate between multiple sclerosis and NMO.
- Sean Pittock, MD, Associate Professor in the Department of Neurology and Co-Director of the Clinical Neuroimmunology Laborator, and consultant in the Division of Clinical Biochemistry and Immunology at Mayo Clinic
Beyond Hot Topics
Beyond Hot Topics is a 30-minute conference call during which the Hot Topic presenter answers questions submitted by e-mail. Beyond Hot Topics for NMO was held on April 15, 2010 at 2:00pm CST. Read the transcript.
Forward to a Colleague
If you have questions, e-mail